keyword
https://read.qxmd.com/read/38646979/challenges-in-the-management-of-new-daily-persistent-headache-at-a-tertiary-headache-center-a-retrospective-real-world-evidence-study
#1
JOURNAL ARTICLE
Thor Linnet, Marwa Hussein, Henrik Winther Schytz, Lars Bendtsen, Faisal Mohammad Amin
OBJECTIVE: In this retrospective cross-sectional real-world evidence study from the Danish Headache Center (DHC), a national tertiary headache center in Denmark, we sought to identify potential pharmacological agents for the treatment of new daily persistent headache (NDPH). BACKGROUND: NDPH is an enigmatic headache disorder with abrupt onset and chronic duration for which evidence-based treatments are lacking. NDPH is a diagnosis of exclusion, for which secondary headaches must be ruled out and the etiology remains idiopathic...
April 22, 2024: Headache
https://read.qxmd.com/read/38646505/adverse-and-serious-adverse-events-incidence-of-pharmacological-interventions-for-managing-chronic-and-episodic-migraine-in-adults-a-systematic-review
#2
JOURNAL ARTICLE
Seyran Naghdi, Martin Underwood, Anna Brown, Manjit Matharu, Callum Duncan, Natasha Davies, Aiva Aksentyte, Hema Mistry
BACKGROUND: Migraine is the second most common prevalent disorder worldwide and is a top cause of disability with a substantial economic burden. Many preventive migraine medications have notable side effects that affect different body organs. METHOD: We systematically searched for published randomised controlled trials (RCTs) using terms for migraine/headache and preventive medications. Using eligibility criteria, two reviewers independently assessed the articles...
2024: BMJ neurology open
https://read.qxmd.com/read/38644702/the-effectiveness-of-parenteral-agents-for-pain-reduction-in-patients-with-migraine-presenting-to-emergency-settings-a%C3%A2-systematic-review-and-network-analysis
#3
REVIEW
Scott W Kirkland, Lloyd Visser, Jillian Meyer, Daniela R Junqueira, Sandra Campbell, Cristina Villa-Roel, Benjamin W Friedman, Nana Owusu Essel, Brian H Rowe
OBJECTIVES: To assess the comparative effectiveness and safety of parenteral agents for pain reduction in patients with acute migraine. BACKGROUND: Parenteral agents have been shown to be effective in treating acute migraine pain; however, the comparative effectiveness of different approaches is unclear. METHODS: Nine electronic databases and gray literature sources were searched to identify randomized clinical trials assessing parenteral agents to treat acute migraine pain in emergency settings...
April 2024: Headache
https://read.qxmd.com/read/38643025/migraine-treatment-consensus-document-of-the-spanish-society-of-neurology-sen-spanish-society-of-family-and-community-medicine-semfyc-society-of-primary-care-medicine-semergen-and-spanish-association-of-migraine-and-headache-aemice-on-migraine-treatment
#4
Robert Belvís, Pablo Irimia, Nuria González, Jésica García-Ull, Patricia Pozo-Rosich, Alba López-Bravo, Noemí Morollón, Sonia Quintas, Antoni Plana, Pablo Gregorio Baz, Ana Tentor, Natalia Gallego Artiles, Francisco Javier León, Miguel Pérez Martín, Inés Rivera, Raquel Ramírez, Isabel Colomina, José Miguel Lainez, Julio Pascual
Migraine is a disease with a high prevalence and incidence, in addition to being highly disabling, causing a great impact on the patient's quality of life at a personal, family and work level, but also social, given its high expense due to its direct (care) and indirect (presenteeism and work absenteeism) costs. The multiple and recent developments in its pathophysiological knowledge and in its therapy require updating and, therefore, in this article the Spanish scientific societies most involved in its study and treatment (SEN, SEMFYC and SEMERGEN), together with the Association Spanish Association for Patients with Migraine and other Headaches (AEMICE), we have developed these updated care recommendations...
April 19, 2024: Medicina Clínica
https://read.qxmd.com/read/38642284/the-environment-and-headache-a-narrative-review
#5
REVIEW
Holly Elser, Caroline F G Kruse, Brian S Schwartz, Joan A Casey
PURPOSE OF REVIEW: In this narrative review, we summarize the peer-reviewed literature published between 2017 and 2022 that evaluated ambient environmental risk factors for primary headache disorders, which affect more than half of the population globally. Primary headache disorders include migraine, tension-type headache (TTH), and trigeminal and autonomic cephalalgias (TAC). RECENT FINDINGS: We identified 17 articles that met the inclusion criteria via PubMed or Google Scholar...
April 20, 2024: Current Environmental Health Reports
https://read.qxmd.com/read/38638041/formulation-consideration-of-medicated-chewing-gum-a-review
#6
JOURNAL ARTICLE
Kishan Bobe, Yoesh Suryawanshi, Virendra Gomase, Muizz Kachhi, Chandrashekhar Bobade
In recent times, technological and scientific advances have been made in studying and developing orally delivered medication. Such studies demonstrate the importance of the oral route among patients. The accuracy of drug delivery is very important to achieve a successful therapeutic effect in the case of various pharmaceutical products. A novel drug delivery system adds new benefits or advantages to a drug. This review covers all the aspects of medicated chewing gum (MCG) as a new drug delivery method, including the benefits and drawbacks, manufacturing methods, type of MCG, composition of chewing gum, evaluation parameters, factors that affected the release of API, its pharmaceutical significance, various marketed chewing gum and chewing gum packaging...
April 17, 2024: Recent advances in drug delivery and formulation
https://read.qxmd.com/read/38634515/nonspecific-oral-medications-versus-anti-calcitonin-gene-related-peptide-monoclonal-antibodies-for-migraine-a%C3%A2-systematic-review-and-meta-analysis-of-randomized-controlled-trials
#7
REVIEW
Jennifer Robblee, Sameh M Hakim, John M Reynolds, Teshamae S Monteith, Niushen Zhang, Meredith Barad
OBJECTIVE: To compare calcitonin gene-related peptide monoclonal antibodies (CGRP mAbs) versus nonspecific oral migraine preventives (NOEPs). BACKGROUND: Insurers mandate step therapy with NOEPs before approving CGRP mAbs. METHODS: Databases were searched for class I or II randomized controlled trials (RCTs) comparing CGRP mAbs or NOEPs versus placebo for migraine prevention in adults. The primary outcome measure was monthly migraine days (MMD) or moderate to severe headache days...
April 18, 2024: Headache
https://read.qxmd.com/read/38633587/migraine-and-its-treatment-from-the-medicinal-chemistry-perspective
#8
REVIEW
Ezgi Pehlivanlar, Simone Carradori, Rahime Simsek
Migraine is a disease of neurovascular origin that affects the quality of life of more than one billion people and ranks sixth among the most common diseases in the world. Migraine is characterized by a moderate or severe recurrent and throbbing headache, accompanied by nausea, vomiting, and photo-phonophobia. It usually starts in adolescence and is twice as common in women as in men. It is classified as with or without aura and has chronic or acute treatment types according to the frequency of occurrence. In acute treatment, analgesics that relieve pain in the fastest way are preferred, while there are different options in chronic treatment...
April 12, 2024: ACS Pharmacology & Translational Science
https://read.qxmd.com/read/38626410/surgical-interventions-for-intractable-migraine-a-systematic-review-and-meta-analysis
#9
JOURNAL ARTICLE
Tahani Alrahbeni, Ahmed Mahal, Anas Alkhouri, Hadil Faris Alotaibi, Vineet Rajagopal, Ashish Behera, Khalid Al-Mugheed, Mahalaqua Nazli Khatib, Shilpa Gaidhane, Quazi Syed Zahiruddin, Muhammed Shabil, Ganesh Bushi, Sarvesh Rustagi, Neelima Kukreti, Prakasini Satapathy, Ranjan K Mohapatra, Arkadiusz Dziedzic, Bijaya Kumar Padhi
BACKGROUND: Migraine affects approximately 14-15% of the global population, contributing to nearly 5% of the world's health burden. When drug treatments prove ineffective for intractable migraines, highly specific surgical interventions emerge as potential solutions. We aimed to analyze surgical approaches for these refractory or intractable migraines through a systematic review and meta-analysis. METHODS: We conducted a literature search across databases such as PubMed, Scopus, Web of Science, and Embase, focusing on studies related to migraines and surgical outcomes...
April 15, 2024: International Journal of Surgery
https://read.qxmd.com/read/38619053/vestibular-migraine-an-update
#10
JOURNAL ARTICLE
Maria D Villar-Martinez, Peter J Goadsby
PURPOSE OF REVIEW: We performed a narrative review of the recent findings in epidemiology, clinical presentation, mechanisms and treatment of vestibular migraine. RECENT FINDINGS: Vestibular migraine is an underdiagnosed condition that has a high prevalence among general, headache and neuro-otology clinics. Vestibular migraine has a bimodal presentation probably associated with a hormonal component in women. These patients could have a complex clinical phenotype including concomitant autonomic, inflammatory or connective tissue conditions that have a higher prevalence of psychological symptoms, which may mistakenly lead to a diagnosis of a functional neurological disorder...
April 16, 2024: Current Opinion in Neurology
https://read.qxmd.com/read/38617553/sensory-processing-difficulties-and-occupational-therapy-outcomes-for-functional-neurological-disorder-a-retrospective-cohort-study
#11
JOURNAL ARTICLE
Kathryn E McCombs, Julie MacLean, Sara A Finkelstein, Susan Goedeken, David L Perez, Jessica Ranford
BACKGROUND AND OBJECTIVES: Occupational therapy (OT) consensus recommendations and articles outlining a sensory-based OT intervention for functional neurological disorder (FND) have been published. However, limited research has been conducted to examine the efficacy of OT interventions for FND. We performed a retrospective cohort study aimed at independently replicating preliminarily characterized sensory processing difficulties in patients with FND and reporting on clinical outcomes of a sensory-based OT treatment in this population...
June 2024: Neurology. Clinical Practice
https://read.qxmd.com/read/38615241/potential-of-focal-cortical-dysplasia-in-migraine-pathogenesis
#12
JOURNAL ARTICLE
Michal Fila, Lukasz Przyslo, Marcin Derwich, Ezbieta Pawlowska, Janusz Blasiak
Focal cortical dysplasias are abnormalities of the cerebral cortex associated with an elevated risk of neurological disturbances. Cortical spreading depolarization/depression is a correlate of migraine aura/headache and a trigger of migraine pain mechanisms. However, cortical spreading depolarization/depression is associated with cortical structural changes, which can be classified as transient focal cortical dysplasias. Migraine is reported to be associated with changes in various brain structures, including malformations and lesions in the cortex...
April 1, 2024: Cerebral Cortex
https://read.qxmd.com/read/38613735/therapeutic-patient-education-as-part-of-the-physiotherapy-management-of-adults-with-headache-a-scoping-review
#13
REVIEW
Sarah Mingels, Marita Granitzer, Kerstin Luedtke, Wim Dankaerts
PURPOSE OF REVIEW: Physiotherapy interventions for headache mostly include exercise and manual therapy. Yet, the complex nature of headache, sometimes characterized by symptoms of facilitated central pain mechanisms, demands an individualized approach in which therapeutic patient education could be supportive. This scoping review aimed to summarize the position of therapeutic patient education within the physiotherapy management of adults with headache. PubMed, EMBASE, Web of Science, and Scopus were searched...
April 13, 2024: Current Pain and Headache Reports
https://read.qxmd.com/read/38613233/medication-underuse-headache
#14
REVIEW
Wanakorn Rattanawong, Alan Rapoport, Anan Srikiatkhachorn
BACKGROUND: Many risk factors have been associated with migraine progression, including insufficient and ineffective utilization of migraine medications; however, they have been inadequately explored. This has resulted in suboptimal usage of medications without effective altering of prescribing recommendations for patients, posing a risk for migraine chronification. METHODS: Our aim is to conduct a comprehensive review of the available evidence regarding the underuse of migraine medications, both acute and preventive...
April 2024: Cephalalgia: An International Journal of Headache
https://read.qxmd.com/read/38610729/reporting-quality-and-risk-of-bias-analysis-of-published-rcts-assessing-anti-cgrp-monoclonal-antibodies-in-migraine-prophylaxis-a-systematic-review
#15
REVIEW
Dimitrios Rikos, Michail Vikelis, Emmanouil V Dermitzakis, Panagiotis Soldatos, Dimitrios Rallis, Jobst Rudolf, Anna P Andreou, Andreas A Argyriou
Objective: Phase II/III randomized clinical trials (RCTs) are vulnerable to many types of bias beyond randomization. Insights into the reporting quality of RCTs involving migraine patients treated with monoclonal antibodies targeting the calcitonin gene-related peptide system (anti-CGRP MAbs) are currently lacking. Our aim was to analyze the reporting quality of phase II/III RCTs involving migraine patients treated with anti-CGRP MAbs. Methods: A systematic search was performed on the PubMed and EMBASE databases, according to PRISMA guidelines, for relevant RCTs in either episodic or chronic migraine prevention...
March 28, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38606939/current-state-of-evidence-for-neuroimaging-paradigms-in-management-of-acute-ischemic-stroke
#16
REVIEW
Amrou Sarraj, Deep K Pujara, Bruce Cv Campbell
Stroke is the chief differential diagnosis in patient presenting to the emergency room with abrupt onset focal neurological deficits. Neuroimaging, including non-contrast computed tomography (CT), magnetic resonance imaging (MRI), vascular and perfusion imaging, is a cornerstone in the diagnosis and treatment decision-making. This review examines the current state of evidence behind the different imaging paradigms for acute ischemic stroke diagnosis and treatment, including current recommendations from the guidelines...
April 12, 2024: Annals of Neurology
https://read.qxmd.com/read/38600467/reconceptualizing-autonomic-function-testing-in-migraine-a-systematic-review-and-meta-analysis
#17
REVIEW
Antun R Pavelić, Karin Zebenholzer, Christian Wöber
BACKGROUND: Autonomic nervous system (ANS) testing has aided in our ability to evaluate autonomic dysfunction in migraine patients. We reviewed the literature in multiple databases which investigate ANS function in migraine patients and healthy subjects. METHODS: This systematic review and meta-analysis examined the respective deep breathing, Valsalva manoeuvre, orthostatic and isometric challenge results, using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Meta-analyses of Observational Studies in Epidemiology (MOOSE) statements...
April 10, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38597252/efficacy-of-various-exercise-interventions-for-migraine-treatment-a-systematic-review-and-network-meta-analysis
#18
REVIEW
Álvaro Reina-Varona, Beatriz Madroñero-Miguel, José Fierro-Marrero, Alba Paris-Alemany, Roy La Touche
OBJECTIVE: To compare various exercise modalities' efficacy on migraine frequency, intensity, duration, and disability. BACKGROUND: Exercise has been shown to be an effective intervention to reduce migraine symptoms and disability; however, no clear evidence exists regarding the most effective exercise modalities for migraine treatment. METHODS: A systematic review was performed in PubMed, PEDro, Web of Science, and Google Scholar. Clinical trials that analyzed the efficacy of various exercise modalities in addressing the frequency, intensity, duration, and disability of patients with migraine were included...
April 10, 2024: Headache
https://read.qxmd.com/read/38596173/first-intravenous-thrombolysis-for-pcys194arg-notch-3-mutation-in-a-moroccan-cadasil-patient-with-stroke
#19
Mohamed Amine Mnaili
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) is caused by mutations in the NOTCH3 gene. Clinical manifestations of CADASIL include lacunar infarcts, transient ischemic attacks, dementia, migraine, and psychiatric disorders. Cerebral MRI can show signal abnormalities in the basal ganglia and white matter, especially characteristic when located in the anterior part of the temporal lobe and external capsules. We report CADASIL patient treated with intravenous tenectelase for acute ischemic stroke, and we present a review of literature aimed to report effectiveness and safety of intravenous thrombolysis in CADASIL patients...
June 2024: Radiology Case Reports
https://read.qxmd.com/read/38594235/pharmacogenomic-study-a-pilot-study-of-the-effect-of-pharmacogenomic-phenotypes-on-the-adequate-dosing-of-verapamil-for-migraine-prevention
#20
JOURNAL ARTICLE
Yi-Chieh Chen, Han Wang, Jayawant N Mandrekar, Carrie E Robertson, Amaal J Starling, Fred M Cutrer, Chia-Chun Chiang
OBJECTIVE: To investigate factors affecting the efficacy and tolerability of verapamil for migraine prevention using individual pharmacogenomic phenotypes. BACKGROUND: Verapamil has a wide range of dosing in headache disorders without reliable tools to predict the optimal doses for an individual. METHODS: This is a retrospective chart review examining adults with existing pharmacogenomic reports at Mayo Clinic who had used verapamil for migraine...
April 9, 2024: Pharmacogenomics Journal
keyword
keyword
96067
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.